整合临床数据、深度学习与影像组学预测接受免疫检查点抑制剂治疗的非小细胞肺癌患者的疗效反应
本研究回顾性纳入228例接受检查点阻断治疗的非小细胞肺癌患者,按7:3随机分为训练组159例和验证组69例,构建整合临床数据、深度学习和影像组学的多模态模型CRDL。CRDL在训练组AUC为0.976、验证组AUC为0.884,优于最佳单模态及预融合深度学习模型(训练AUC 0.854、验证AUC 0.749)。
要点
- CRDL多模态模型验证组AUC 0.884,训练组AUC 0.976。
- 最佳单模态/预融合深度学习模型训练AUC 0.854、验证AUC 0.749,低于CRDL。
- 模型整合胸部CT的深度学习特征与影像组学特征及临床数据。
核心结论
- CRDL模型能准确预测非小细胞肺癌患者的免疫治疗反应,提供一种可靠的非侵入性检测手段。
研究设计与样本
- 回顾性研究,纳入纪念斯隆-凯特琳癌症中心的228例肺癌患者,PD-L1表达水平不一。
- 228例按7:3随机分为训练组159例和验证组69例。
- 使用PyRadiomics包提取影像组学特征,通过深度卷积神经网络从胸部CT图像获取深度学习特征,并收集临床数据。
- 采用t检验和最小绝对收缩与选择算子回归进行特征降维,单模态模型和预融合模型用随机森林构建,后融合模型用支持向量机构建,以受试者工作特征曲线下面积(AUC)评价性能。
诊断标准与关键数值
- 共提取512个深度学习特征和382个影像组学特征。
- CRDL模型验证集AUC为0.884,训练集AUC为0.976。
- 最佳深度学习模型在单模态和预融合设置下训练AUC为0.854、验证AUC为0.749,低于CRDL。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Determining predictive biomarkers for immunotherapy response in non-small cell lung cancer (NSCLC) patients is a complex task.
OBJECTIVE: This research aimed to develop a multimodal model (CRDL) integrating clinical data, deep learning (DL), and radiomics (Rad) to predict immune responses in NSCLC patients receiving checkpoint blockade therapies. This study also evaluated whether CRDL outperforms unimodal, pre-fusion models (Pre-FMs) and post-fusion models (Post-FMs).
METHODS: This is a retrospective study that utilized data from 228 lung cancer patients at the Memorial Sloan Kettering Cancer Center, with varying Programmed Death-Ligand 1(PD-L1) expression levels among the patients. 228 NSCLC patients were randomly divided into two groups in a 7:3 ratio: the training cohort (n=159) and the validation cohort (n=69). Image histological features were extracted using the "PyRadiomics" package, and DL features were obtained through the deep convolutional neural network from chest computed tomography images, and clinical data from the patients were also collected. Feature reduction was performed using t-tests and the Least absolute shrinkage and selection operator regression. Unimodal modal and Pre-FMs were constructed using random forests, while the post-fusion model was developed using a support vector machine approach. The performance of the model was measured by the area under the receiver operating characteristic curve (AUC).
RESULTS: 512 DL features and 382 Rad features were extracted. The CRDL model demonstrated superior performance with AUC values of 0.884 in the validation dataset and 0.976 in the training dataset, surpassing the best DL model in both unimodal and pre-fusion settings, which had training and validation AUCs of 0.854 and 0.749.
CONCLUSION: The CRDL model accurately forecasts immunotherapy responses in NSCLC patients, offering one dependable non-invasive test.
引用
- Wang C, Li Y, Ji Y, et al. Predictions of Response in Non-small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Using Clinical Data, Deep Learning, and Radiomics. Acad Radiol. 2025. PMID: 41087235. doi:10.1016/j.acra.2025.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。